Medicines recallMHRA
Lercanidipine Hydrochloride 10mg Film-Coated Tablets recalled over a strength or dose problem
Accord-UK Ltd is recalling one batch of Lercanidipine Hydrochloride 10mg Tablets due to a packaging mix-up involving the incorrect strength.
Check your product
Only products that match these details are covered. Have your pack in front of you.
3 identifiers listed for this notice.
Lercanidipine Hydrochloride 10mg Film-Coated Tablets 28
- Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
- M2510877
- ExpiryOn the carton, blister or label.
- 11/2028
- First distributedOn the product, its label or its packaging.
- 24/06/2026
What to do now
The problem with Lercanidipine Hydrochloride 10mg Film-Coated Tablets is strength: the dose in the affected batches may be higher or lower than the label says.
- Keep taking your medicine unless a healthcare professional tells you otherwise.
- Check the batch number and expiry date on your pack against the list on this page.
- If it matches, your pharmacist can swap it or arrange an alternative.
- Report suspected side effects to the MHRA Yellow Card scheme.
Why it matters. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.
Symptoms and when to get help
Look out for
- a side effect you have not had before
- your condition not being controlled as well as usual
Get help urgently
- signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
- if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111
This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.
Replacements and prescriptions
Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement.
If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.
From the official notice
Published by the Medicines and Healthcare products Regulatory Agency (EL(26)A/45). Quoted as issued.
Summary
Accord-UK Ltd is recalling one batch of Lercanidipine Hydrochloride 10mg Tablets due to a packaging mix-up involving the incorrect strength.
The risk
DMRC reference number DMRC - 41285957 Marketing Authorisation Holder
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
This recall is at the pharmacy and wholesaler level and not directed to patient level as 20 mg remains within the authorised therapeutic dose range for routine use of this product. The tablets have distinct colours and the occurrence of the defect is currently anticipated to be very low. However, should a patient present a pack with the incorrect medicine, pharmacy teams should exercise their professional judgement to supply the correct medication.
Accord has received a single report of a carton of Accord-UK Ltd Lercanidipine Hydrochloride 10 mg Tablets containing a blister strip of Lercanidipine Hydrochloride 20 mg Tablets and are being recalled as a precautionary measure. 20 mg remains within the authorised therapeutic dose range for routine use of this product. The tablets have distinct colours and the occurrence of the defect is currently anticipated to be very low.
If you were prescribed Lercanidipine Hydrochloride 10 mg Tablets, and received an Accord pack with batch number M2510877, please carefully check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1).
If the carton contains blister strips that are labelled as Lercanidipine Hydrochloride 10 mg Tablets, you do not need to take further action and may continue to take the tablets.
If the carton contains a blister strip that is labelled as Lercanidipine Hydrochloride 20 mg Tablets, do not take the medicine, contact your pharmacy.
If you believe you have taken the Lercanidipine 20 mg Tablets and are currently experiencing any side effects such as dizziness, headache, flushing or palpitations then please seek immediate medical advice. Please take the leaflet that came with your medicine and any remaining tablets with you to your pharmacy or GP practice.
If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals involved in your treatment.
Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Advice for patients
Accord has received a single report of a carton of Accord-UK Ltd Lercanidipine Hydrochloride 10 mg Tablets containing a blister strip of Lercanidipine Hydrochloride 20 mg Tablets and are being recalled as a precautionary measure. 20 mg remains within the authorised therapeutic dose range for routine use of this product. The tablets have distinct colours and the occurrence of the defect is currently anticipated to be very low.
If you were prescribed Lercanidipine Hydrochloride 10 mg Tablets, and received an Accord pack with batch number M2510877, please carefully check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1).
If the carton contains blister strips that are labelled as Lercanidipine Hydrochloride 10 mg Tablets, you do not need to take further action and may continue to take the tablets.
If the carton contains a blister strip that is labelled as Lercanidipine Hydrochloride 20 mg Tablets, do not take the medicine, contact your pharmacy.
If you believe you have taken the Lercanidipine 20 mg Tablets and are currently experiencing any side effects such as dizziness, headache, flushing or palpitations then please seek immediate medical advice. Please take the leaflet that came with your medicine and any remaining tablets with you to your pharmacy or GP practice.
If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals involved in your treatment.
Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Open the MHRA notice
Questions
Why has Lercanidipine Hydrochloride 10mg Film-Coated Tablets been recalled?
The problem with Lercanidipine Hydrochloride 10mg Film-Coated Tablets is strength: the dose in the affected batches may be higher or lower than the label says. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.
How do I know if my medicine is affected?
Compare the batch code, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.
What should I do now?
Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.
Do I need a new prescription?
Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement. If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.